These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6884975)

  • 1. Dacarbazine (DTIC)-induced human liver damage light and electron-microscopic findings.
    Dancygier H; Runne U; Leuschner U; Milbradt R; Classen M
    Hepatogastroenterology; 1983 Jun; 30(3):93-5. PubMed ID: 6884975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
    Frosch PJ; Czarnetzki BM; Macher E; Grundmann E; Gottschalk I
    J Cancer Res Clin Oncol; 1979; 95(3):281-6. PubMed ID: 528568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute liver dystrophy with thrombosis of hepatic veins: a fatal complication of dacarbazine treatment.
    Féaux de Lacroix W; Runne U; Hauk H; Doepfmer K; Groth W; Wacker D
    Cancer Treat Rep; 1983 Sep; 67(9):779-84. PubMed ID: 6883354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic veno-occlusive disease due to DTIC.
    Asbury RF; Rosenthal SN; Descalzi ME; Ratcliffe RL; Arseneau JC
    Cancer; 1980 May; 45(10):2670-4. PubMed ID: 7379000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper and liver injury--experimental studies on the dogs with biliary obstruction and copper loading.
    Azumi N
    Hokkaido Igaku Zasshi; 1982 May; 57(3):331-49. PubMed ID: 7129350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal hepatic toxicity of DTIC: a new case.
    Quinio P; Bouche O; Lambolais C; Savry C; Cartier H; Egreteau JP
    Intensive Care Med; 1997 Oct; 23(10):1099. PubMed ID: 9407248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Budd-Chiari syndrome following dacarbazine therapy of malignant melanoma--an avoidable complication?].
    Leyh F; Winzer M; Weber M; Hypa F
    Z Hautkr; 1985 Jun; 60(12):961-72. PubMed ID: 4024678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergy-induced hepatic toxicity associated with dacarbazine.
    McClay E; Lusch CJ; Mastrangelo MJ
    Cancer Treat Rep; 1987 Feb; 71(2):219-20. PubMed ID: 3802121
    [No Abstract]   [Full Text] [Related]  

  • 9. Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice.
    Walker RM; Racz WJ; McElligott TF
    Am J Pathol; 1983 Dec; 113(3):321-30. PubMed ID: 6650662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
    Runne U; Doepfmer K; Antz H; Groth W; FEAUX DE Lacroix W
    Dtsch Med Wochenschr; 1980 Feb; 105(7):230-3. PubMed ID: 6986251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide induced hepatotoxicity.
    Walker RM; McElligott TF
    J Pathol; 1981 Dec; 135(4):301-14. PubMed ID: 7328448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanoma.
    Erichsen C; Jönsson PE
    J Surg Oncol; 1984 Dec; 27(4):268-70. PubMed ID: 6503301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
    Voigt H; Caselitz J; Jänner M
    Klin Wochenschr; 1981 Mar; 59(5):229-36. PubMed ID: 7218735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dacarbazine in malignant melanoma. Rare, severe side-effect: Budd-Chiari-syndrome (author's transl)].
    Doering C; Pickartz H; Orfanos CE; Altenähr E
    Z Hautkr; 1982 Jul; 57(13):971-80. PubMed ID: 7113323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
    J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Budd-Chiari syndrome in DTIC therapy].
    Swensson-Beck H; Trettel WH
    Hautarzt; 1982 Jan; 33(1):30-1. PubMed ID: 7085277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological aspects of dacarbazine-induced human liver damage.
    Paschke R; Heine M
    Hepatogastroenterology; 1985 Dec; 32(6):273-5. PubMed ID: 4093126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
    Bolling R; Meyer-Hamme S; Schauder S
    Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].
    Balda BR; Bassermann R
    MMW Munch Med Wochenschr; 1980 May; 122(21):792-4. PubMed ID: 6771598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanoma.
    Goodnight JE; Moseley HS; Eilber FR; Sarna G; Morton DL
    Cancer Treat Rep; 1979; 63(11-12):2005-7. PubMed ID: 393385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.